Company Overview
American HealthCare Capital is pleased to introduce a well-established, boutique, high-end dental laboratory for sale in the Pacific Northwest. This dental lab is affiliated with one of the top advanced dental training programs in the country and specializes in high-end cosmetic and restorative work, supported by an experienced team of master ceramists and designers. Based in the Midwest, it operates from a 6,000-square-foot modern facility.
The company is seeking a strategic or financial acquirer to support its next phase of growth. It has maintained strong EBITDA margins and recently completed two mergers as part of a targeted regional consolidation strategy, expanding its footprint to three locations.
Financial Overview
The company has demonstrated strong revenue growth and expanding operations through strategic consolidation. Total revenue increased from $885,000 in 2024 to an annualized $1.0 million in 2025, with projections reaching $1.8 million in 2026 as all three labs operate under a merged structure. EBITDA is expected to rise from $452,000 in 2024 to $315,000 annualized in 2025, and further to $600,000 in 2026, reflecting continued integration and efficiency gains. Profit margins are projected to improve from 25% in 2025 to 33% in 2026, signaling a return to stronger profitability as the mergers mature.
| 2024 | 1/1- 8/31-2025 | 2025- ANNUALIZED* | 2026** | |
| Revenue Parent | $563,543.84 | MERGED | MERGED | $600,000 |
| Revenue AS | $321,776.29 | $400,000 | ||
| Revenue AE | $110,000 | $800,000.00 | ||
| Total Revenue | $885,320.13 | $763,741 | $1,018,321 | $1,800,000 |
| EBITDA- Parent | $211,681.00 | MERGED | ||
| EBITDA- AS | $240,550.00 | |||
| EBITDA- AE | ||||
| EBITDA- Combined | $452,231.00 | $194,050.00 | $315,000 | $600,000.00 |
| Profit Margin % | 51.08% | 25.408% | 30.93% | 33.33% |
*2025 Annualized ** AE 2025 Revenue is projection for Q4 only as the company will be acquired by 10/1/25 *2026 Revenue and EBITDA is projected based on all 3 labs combined
Exit Strategy and Ownership Transition
The seller is stepping back for family health reasons and is open to flexible transaction structures including equity retention and continued management participation to help the acquirer expand via additional lab acquisitions.
Asking Price
The asking price for this opportunity is $3,000,000, including an earn-out tied to 2026 performance. The asking price excludes cash, accounts receivables, working capital, and any real estate holdings.
